Extracorporeal shock wave therapy (ESWT) technology is well known for repairing, remodeling, and regenerating tissue by sending high-speed energy waves through the body. ESWT has also been shown to increase blood flow, increase wound vascular density, and induce an antibacterial effect. ESWT has been demonstrated to be effective for a wide range of wound types, including diabetic foot ulcers, second-degree burns, post-surgical wounds, and traumatic lesions.
Diabetic Foot Complications and Economic Burden
Diabetic Foot Ulcers are among the most chronic foot conditions characterized by ulceration, infection, gangrene, recurrence of infection, and can lead to limb loss and even death. Chronic wounds are a burden for each patient and significantly reduce the quality of life. Diabetes patients have a 25% increased risk of developing foot ulcers, and one lower limb amputation in diabetes patients occurs every 30 seconds around the world. As a result, cost-effective, non-invasive, and efficacious treatments like ESWT are a required alternative to move wound chronicity toward healing while lowering treatment-related costs.
Moving a chronic wound to an acute status requires adequate wound bed preparation, which can be accomplished through various strategies such as debridement, moisture balance, and reducing bacterial bioburden and inflammation. Extracorporeal shockwave therapy was recently found to increase and expedite the healing of complex soft tissue wounds like DFUs compared to the traditional treatment techniques in DFUs. [5,6] In addition, ESWT appears to have distinct effects on intact and injured peripheral nerves, suggesting the presence of numerous mechanisms of action, such as neurogenesis. ESWT provides a cost-effective approach compared to hyperbaric oxygen therapy (HBOT), negative pressure wound therapy (NPWT), and cellular and tissue-based products (CTPs).
Physical Principles of ESWT Technology
Not all ESWT technologies are alike. The technology can be differentiated by equipment source, how generated, wave speeds, waveforms, density, and depths differ. ESWT is available in three variations.
- Unfocused ESWT (uESWT) promotes both a physical and biological response to improve healing, by using a more acoustic planar wave that generating larger area shock waves.
- Focused ESWT (fESWT) treats a defined wound area to penetrate a required depth using a higher peak waves and short rise in pressure.
- Radial ESWT (rSWT) are a low-to-medium energy shock wave generated though a barrel of a handpiece device transferred to the skin.
Biological responses in DFUs include:
- Promotes antimicrobial effects
- Improved neovascularization
- Stimulates anti-inflammatory effects
- Increases formation of cytokines and growth factors
- Encourages long-term angiogenesis and epithelialization
- Facilitates tissue repair, remodeling, and regeneration.
Wound Chronicity and Biofilm
Evidence suggests that biofilm is present in the majority of chronic wounds. It is only present in 6% of acute wounds but over 90% of chronic wounds. During biofilm formation, the bacteria’s phenotype changes, leveraging building blocks from both the host and what they produce. As the biofilm forms, the bacteria continue to change their phenotypic to survive in a lower energy state and perform various functions within the colony while simultaneously passing on their resistance to antibiotics to the community. Because each colony of bacteria produces a unique biofilm with its own set of distinguishing characteristics, a clinical strategy must be adjusted to the particulars of that certain biofilm to be effective.
ESWT Sequence of Treatment
ESWT is an outpatient therapy that typically consists of one therapy session per week with a treatment time of 6-8 weeks. A licensed healthcare professional can easily perform this non-invasive therapy. During this treatment, patients reported little or no sensation or pain. There are no aesthetic agents required, and there are no side effects. Patients with cancer, coagulation disorders, pregnancy, morbid obesity (BMI >40), wounds larger than 16sq cm, and using on the anatomical locations head and lungs are all contraindications to shockwave therapy.
ESWT jump-starts the healing process and aids in eradicating biofilm. Furthermore, benefits include increased biological response growth factors, tissue regeneration, inflammatory modulation, and improved micro-vascularization and micro-circulation. Extracorporeal shock wave therapy (ESWT) can significantly shorten the healing time and minimize treatment inefficacy for diabetic foot ulcers (DFUs). ESWT provides patients with a more convenient and cost-effective approach to wound care management than standard wound care.
- Is There A Role For ESWT In Wound Care? (2006, July). HMP Global Learning Network. Retrieved July 25, 2022, from https://www.hmpgloballearningnetwork.com/site/podiatry/article/5828
- Attinger C, Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care (New Rochelle). 2012 Jun;1(3):127-132. doi: 10.1089/wound.2011.0333. PMID: 24527292; PMCID: PMC3839004.
- Zhang L, Weng C, Zhao Z, Fu X. Extracorporeal shock wave therapy for chronic wounds: a systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2017;25:697-706.
- Cho KH. Caparon MG. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol. 2005;57:6–1545.
- Wang CJ, Cheng JH, Kuo YR, Schaden W, Mittermayr R. Extracorporeal shockwave therapy in diabetic foot ulcers. Int J Surg. 2015 Dec;24(Pt B):207-9. doi: 10.1016/j.ijsu.2015.06.024. Epub 2015 Jun 12. PMID: 26079500.
- Huang et al (2019). Extracorporeal Shock Wave Therapy for Treating Foot Ulcers in Adults With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Canadian Journal of Diabetes, 44 (2020) 196-204
- Armstrong DG, Bauer K, Bohn G, et al. Principles of best diagnostic practice in tissue repair and wound healing; an expert consensus. Diagnostics (Basel). 2020;11(1):50.https://doi.org/10.3390/diagnostics11010050. Accessed July 26, 2022.
- Chaussy C.G., Fuchs G.J. Current state and future developments of noninvasive treatment of human urinary stones with extracorporeal shock wave lithotripsy.J Urol. 1989;141:782–789
- Smith D.P., Graham J.B., Prystowsky J.B., Dalkin B.L., Nemcek A.A., Jr. The effects of ultrasound-guided shock waves during early pregnancy in Sprague-Dawley rats. J Urol. 1992;147:231–234.
- Mittermayr R, Antonic V, Hartinger J, Kaufmann H, Redl H, Téot L, Stojadinovic A, Schaden W. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen. 2012 Jul-Aug;20(4):456-65. doi: 10.1111/j.1524-
- International Diabetes Federation. Time to Act: diabetes and foot care. Brussels: International Diabetes Federation, 2005.
- Hausner T, Nógrádi A. The use of shock waves in peripheral nerve regeneration: new perspectives? Int Rev Neurobiol. 2013;109:85-98. doi: 10.1016/B978-0-12-420045-6.00003-1. PMID: 24093607.
- Goertz O, Lauer H, Hirsch T, Ring A, Lehnhardt M, Langer S, et al. Extracorporeal shock waves improve angiogenesis after full thickness burn. Burns. 2012;38(Suppl 7):S1010-S1018
- Marks W, Jackiewicz A, Witkowski Z, Kot J, Deja W, Lasek J. Extracorporeal shock-wave therapy (ESWT) with a new-generation pneumatic device in the treatment of heel pain. A double blind randomised controlled trial. Acta Orthopaedica Belgica. 2008;74:98-101
- Gollwitzer H, Gloeck T, Roessner M, Langer R, Horn C, Gerdesmeyer L, et al. Radial extracorporeal shock wave therapy (rESWT) induces new bone formation in vivo: Results of an animal study in rabbits. Ultrasound in Medicine & Biology. 2013;39(1):126-133
- What is Shock Therapy? Softwave Tissue Regeneration Technologies. https://softwavetrt.com/shock-wave-therapy/Retrieved July 30, 2022.